Loading...

OTC Markets

Totals

Securities

12,253

Dollar Vol

$2.5B

Share Vol

5.2B

Trades

355,797

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Market Activity
Stock
BTTX
Financials

BTTX
Better Therapeutics, Inc.

Common Stock

Financials

Fiscal year ends 12/31

| Values in 000s USD

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

2022

12/30/2022

2021

12/30/2021

2020

12/30/2020

12/30/2022

2022-12-31 00:00:00

12/30/2021

2022-12-31 00:00:00

12/30/2020

2022-12-31 00:00:00

Revenues

Total Revenue

Cost of Revenue

Gross Profit

Operating Expenses

Research and Development

16,440

19,436

16,440

3,660

16,440

Sales, General and Admin

21,822

11,124

21,822

2,671

21,822

Non-Recurring Items

Other

Total Expenses

38,262

30,560

38,262

6,331

38,262

Operating Income

(38,262)

(30,560)

(38,262)

(6,323)

(38,262)

Income from Continuing Operations

Additional Income / Expense Items

(10,390)

189

Earnings Before Interest and Taxes

(38,262)

(30,560)

(38,262)

(6,323)

(38,262)

Interest Expense

(1,491)

(185)

(1,491)

(100)

(1,491)

Earnings Before Tax

(39,753)

(40,488)

(39,753)

(6,234)

(39,753)

Income Tax

(153)

153

Minority Interest

Equity Earnings

Net Income Cont. Operations

(39,760)

(40,335)

(39,760)

(6,387)

(39,760)

Non-Recurring Events

Discontinued Operations

Extraordinary Operations

Effect of Accounting Changes

Net Income

(39,760)

(40,335)

(39,760)

(6,387)

(39,760)

Key Financial Ratios

Earnings Per Share

-1.69

-3.11

-1.69

-0.79

-1.69

Price/Earnings

-0.6538

Gross Margin

Operating Margin

-790.375

Financial data presented is provided by Edgar Online and may differ from information contained in the issuer's annual and periodic reports, which are available under the "Disclosure" tab.

Neither the issuer nor OTC Markets Group is liable for any errors, omissions or other defects in the data presented below, or for any decisions taken in reliance of the data.

For information not originally reported in U.S. Dollars, conversion is based on applicable exchange rate on the last day of the period reported.

© 2025 EDGAR®Online LLC, a subsidiary of OTC Markets Group. All rights reserved. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Market Groups Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.